This book offers an in-depth analysis of the EU regulation of genome edited plants and its compatibility with WTO law and the Comprehensive Economic Trade Agreement (CETA). It analyses in detail whether the EU authorisation procedures, labelling requirements and the EUs opt-out mechanism and its application to genome edited plants are compatible with the EUs obligations under the Agreement on Sanitary and Phytosanitary Measures (SPS Agreement), the Agreement on Technical Barriers to Trade (TBT Agreement), the General Agreement on Tariffs and Trade (GATT) and CETA.  Based on this analysis, the EU Commissions proposal for a new regulation on plants produced by certain new genomic techniques is discussed. Also, the book provides suggestions to further improve the EU Commissions proposal.  The books analysis is not only relevant for legal researchers in the field of biotechnology and international economic law, but also discusses regulatory aspects that are highly relevant for the scientific and industrial sector involved in biotechnology.